Literature DB >> 23592857

Response to "Implications of Trichomonas vaginalis nucleic acid amplification testing on medical training and practice".

C C Ginocchio, K Chapin, J S Smith, J Snook, C S Hill, J Aslanzadeh, C A Gaydos.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23592857      PMCID： PMC3647950          DOI： 10.1128/JCM.00222-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  4 in total

1.  A Trich-y question: should Trichomonas vaginalis infection be reportable?

Authors:  Brooke E Hoots; Thomas A Peterman; Elizabeth A Torrone; Hillard Weinstock; Elissa Meites; Gail A Bolan
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

2.  Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.

Authors:  C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

Review 3.  APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.

Authors:  Kimberle Chapin; Sarah Andrea
Journal:  Expert Rev Mol Diagn       Date:  2011-09       Impact factor: 5.225

4.  Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment.

Authors:  Charlotte A Gaydos; Mathilda R Barnes; Nicole Quinn; Mary Jett-Goheen; Yu-Hsiang Hsieh
Journal:  Sex Transm Infect       Date:  2013-01-26       Impact factor: 3.519
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.